Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Amin

Showing results (801-810 of 818) with videos related to

Pageof 82
Sort By:
Human Mutation|November 6, 2022
KBTBD13 is a novel cardiomyopathy geneJosine M de Winter, Karlijn Bouman, Joshua Strom, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok GovernoratesKarwan M-Amen, Omiad S Abdullah, Ahmed M S Amin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of GlioblastomaJ F Georges, C Clay, S Amin, et al.
Circulation|October 11, 2024
A Rare Noncoding Enhancer Variant in <i>SCN5A</i> Contributes to the High Prevalence of Brugada Syndrome in ThailandRoddy Walsh, John Mauleekoonphairoj, Isabella Mengarelli, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Nature Genetics|November 21, 2024
Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilienceSean J Jurgens, Joel T Rämö, Daria R Kramarenko, et al.
Pageof 82

Showing results (801-810 of 818) with videos related to

Sort By:
Pageof 82
Human Mutation|November 6, 2022
KBTBD13 is a novel cardiomyopathy geneJosine M de Winter, Karlijn Bouman, Joshua Strom, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok GovernoratesKarwan M-Amen, Omiad S Abdullah, Ahmed M S Amin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of GlioblastomaJ F Georges, C Clay, S Amin, et al.
Circulation|October 11, 2024
A Rare Noncoding Enhancer Variant in <i>SCN5A</i> Contributes to the High Prevalence of Brugada Syndrome in ThailandRoddy Walsh, John Mauleekoonphairoj, Isabella Mengarelli, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Nature Genetics|November 21, 2024
Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilienceSean J Jurgens, Joel T Rämö, Daria R Kramarenko, et al.
Pageof 82